87 related articles for article (PubMed ID: 18666838)
1. Evaluation of long-term toxicity of Ad/hIFN-, an Adenoviral vector encoding the human interferon-gamma gene, in nonhuman primates.
Li Y; Shao JY; Liu RY; Zhou L; Chai LP; Li HL; Han HY; Huang BJ; Zeng MS; Zhu XF; Liu Q; Fu LW; Huang W
Hum Gene Ther; 2008 Aug; 19(8):827-39. PubMed ID: 18666838
[TBL] [Abstract][Full Text] [Related]
2. Long-Term toxicity studies in Canine of E10A, an adenoviral vector for human endostatin gene.
Huang BJ; Liu RY; Huang JL; Liang ZH; Gao GF; Wu JX; Huang W
Hum Gene Ther; 2007 Mar; 18(3):207-21. PubMed ID: 17346097
[TBL] [Abstract][Full Text] [Related]
3. A phase I trial of Ad.hIFN-beta gene therapy for glioma.
Chiocca EA; Smith KM; McKinney B; Palmer CA; Rosenfeld S; Lillehei K; Hamilton A; DeMasters BK; Judy K; Kirn D
Mol Ther; 2008 Mar; 16(3):618-26. PubMed ID: 18180770
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of adenovirus-mediated human Gamma Interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia.
Li X; Lu Y; Huang W; Xu H; Chen X; Geng Q; Fan H; Tan Y; Xue G; Jiang X
Hematol Oncol; 2006 Sep; 24(3):151-8. PubMed ID: 16700092
[TBL] [Abstract][Full Text] [Related]
6. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.
Fiedler M; Rödicker F; Salucci V; Lu M; Aurisicchio L; Dahmen U; Jun L; Dirsch O; Pützer BM; Palombo F; Roggendorf M
J Virol; 2004 Sep; 78(18):10111-21. PubMed ID: 15331744
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
8. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector.
Svensson EC; Black HB; Dugger DL; Tripathy SK; Goldwasser E; Hao Z; Chu L; Leiden JM
Hum Gene Ther; 1997 Oct; 8(15):1797-806. PubMed ID: 9358029
[TBL] [Abstract][Full Text] [Related]
9. Long-term toxicity study of rAd5-hTERTC27 in SD rats and Cynomolgus monkeys by intravenous injection.
Yue PJ; He L; Shen QY; Qiu SW; Rong XM; Gong HX; Peng Y
Regul Toxicol Pharmacol; 2015 Mar; 71(2):285-94. PubMed ID: 25592546
[TBL] [Abstract][Full Text] [Related]
10. Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates.
Su C; Cao H; Tan S; Huang Y; Jia X; Jiang L; Wang K; Chen Y; Long J; Liu X; Wu M; Wu X; Qian Q
Toxicol Sci; 2008 Nov; 106(1):242-50. PubMed ID: 18703561
[TBL] [Abstract][Full Text] [Related]
11. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma.
Hillman GG; Slos P; Wang Y; Wright JL; Layer A; De Meyer M; Yudelev M; Che M; Forman JD
Cancer Gene Ther; 2004 Jan; 11(1):61-72. PubMed ID: 14681727
[TBL] [Abstract][Full Text] [Related]
12. [Synergic effect of adenoviral vector-encoding human alpha-fetoprotein and interferon-gamma on immunity against hepatocellular carcinoma in mice].
Tan XH; Zhu Q
Ai Zheng; 2008 Feb; 27(2):155-9. PubMed ID: 18279612
[TBL] [Abstract][Full Text] [Related]
13. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.
Brunetti-Pierri N; Palmer DJ; Beaudet AL; Carey KD; Finegold M; Ng P
Hum Gene Ther; 2004 Jan; 15(1):35-46. PubMed ID: 14965376
[TBL] [Abstract][Full Text] [Related]
14. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
[TBL] [Abstract][Full Text] [Related]
15. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.
Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR
Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713
[TBL] [Abstract][Full Text] [Related]
16. Ad-IFN gamma induces antiproliferative and antitumoral responses in malignant mesothelioma.
Gattacceca F; Pilatte Y; Billard C; Monnet I; Moritz S; Le Carrou J; Eloit M; Jaurand MC
Clin Cancer Res; 2002 Oct; 8(10):3298-304. PubMed ID: 12374702
[TBL] [Abstract][Full Text] [Related]
17. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide.
Lasarte JJ; Corrales FJ; Casares N; López-Díaz de Cerio A; Qian C; Xie X; Borrás-Cuesta F; Prieto J
J Immunol; 1999 May; 162(9):5270-7. PubMed ID: 10228002
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
19. A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma.
Chiocca EA; Smith KM; McKinney B; Palmer CA; Rosenfeld S; Lillehei K; Hamilton A; DeMasters BK; Judy K; Kirn D
Mol Ther; 2008 Mar; 16(3):618-626. PubMed ID: 28178503
[TBL] [Abstract][Full Text] [Related]
20. Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates.
Butti E; Bergami A; Recchia A; Brambilla E; Franciotta D; Cattalini A; Stornaiuolo A; Lachapelle F; Comi G; Mavilio F; Martino G; Furlan R
Gene Ther; 2008 Feb; 15(3):233-8. PubMed ID: 17960158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
